Accolade Inc.

NASDAQ: ACCD · Real-Time Price · USD
7.02
0.00 (0.00%)
At close: Apr 07, 2025, 3:59 PM

Accolade Revenue Breakdown

Period Ending Feb 29, 2024 Feb 28, 2023
Access fees Revenue 300.49M 284.14M
Access fees Revenue Growth +5.75% n/a
Health Care, Patient Service Revenue 113.8M n/a
Health Care, Patient Service Revenue Growth n/a n/a

Operating Expense Breakdown

Period Ending Nov 30, 2024 Aug 31, 2024 May 31, 2024 Feb 29, 2024 Nov 30, 2023 Aug 31, 2023 May 31, 2023 Feb 28, 2023 Nov 30, 2022 Aug 31, 2022 May 31, 2022 Feb 28, 2022 Nov 30, 2021 Aug 31, 2021 May 31, 2021 Feb 28, 2021 Nov 30, 2020 Aug 31, 2020 May 31, 2020 Feb 29, 2020 Nov 30, 2019 Aug 31, 2019 May 31, 2019 Feb 28, 2019 Nov 30, 2018
Selling, General, and Administrative Revenue 41.71M 41.47M 44.2M 39.04M 41.7M 40.34M 41.11M 43.45M 45.06M 45.96M 45.85M 53.1M 46.08M 50.18M 36.51M 20.92M 17.06M 14.33M 12.98M 12.88M 16.48M 13.63M 13.22M 11.28M 11.4M
Selling, General, and Administrative Revenue Growth +0.58% -6.19% +13.23% -6.39% +3.39% -1.89% -5.39% -3.56% -1.95% +0.23% -13.65% +15.24% -8.17% +37.44% +74.55% +22.62% +19.00% +10.41% +0.82% -21.84% +20.90% +3.04% +17.27% -1.04% n/a
Research and Development Revenue 20.59M 22.48M 26.31M 24.19M 23.47M 25.6M 25.9M 24.08M 24.25M 26.19M 26.82M 22.37M 22.85M 22.51M 15.94M 13.33M 13.02M 12.24M 11.37M 8.71M 11.05M 11.3M 11.25M 9.82M 9.33M
Research and Development Revenue Growth -8.40% -14.57% +8.76% +3.08% -8.34% -1.15% +7.55% -0.71% -7.41% -2.32% +19.90% -2.10% +1.48% +41.24% +19.56% +2.40% +6.39% +7.62% +30.52% -21.14% -2.27% +0.51% +14.50% +5.23% n/a
Sales and Marketing Revenue 25.51M 24.93M 28.19M 24.73M 26.23M 24.08M 25.03M 23.54M 25.02M 24.94M 25.61M 23.63M 24.62M 24.01M 14.51M 9.87M 8.64M 7.88M 7.32M 6.85M 7.92M 7.62M 7.66M 6.21M 5.63M
Sales and Marketing Revenue Growth +2.31% -11.57% +14.02% -5.73% +8.95% -3.82% +6.34% -5.93% +0.35% -2.65% +8.39% -4.00% +2.53% +65.48% +47.00% +14.18% +9.68% +7.74% +6.82% -13.58% +4.04% -0.60% +23.34% +10.42% n/a